Title:
【発明の名称】三期経口避妊薬
Document Type and Number:
Japanese Patent JP2002533398
Kind Code:
A
Abstract:
A method of contraception in which an estrogen and a progestogen are administered daily in a three phase sequence for 21 days is disclosed. In the first phase a combination of an estrogen and a progestogen in a low but contraceptively effective daily dosage corresponding in estrogenic activity to 23-28 mug of 17alpha-ethinylestradiol and in progestogenic activity to 0.065-0.75 mg of norethindrone is administered for 5-8 days; followed by the administering of the same dosage of estrogen and a progestogen corresponding in progestogenic activity to 0.25-1.0 mg of norethindrone for 7-11 days; followed by the administering of the same dosage of estrogen and a progestogen corresponding in progestogenic activity to 0.35-2.0 mg of norethindrone for 3-7 days; followed by 4-8 days without administering either an estrogen or a progestogen.
Inventors:
Cyan gold,gary
Rubin, Arcaday
UP Maris, David
Rubin, Arcaday
UP Maris, David
Application Number:
JP2000590643A
Publication Date:
October 08, 2002
Filing Date:
December 08, 1999
Export Citation:
Assignee:
Ortho-McNeill Pharmacy Incorporated
International Classes:
A61K31/565; A61K31/567; A61K31/569; A61K31/57; A61P15/18; (IPC1-7): A61K31/565; A61K31/567; A61K31/569; A61K31/57; A61P15/18
Domestic Patent References:
| JPH04290828A | 1992-10-15 | |||
| JPH04290830A | 1992-10-15 |
Foreign References:
| WO1997001342A1 | 1997-01-16 | |||
| WO1996032114A1 | 1996-10-17 |
Attorney, Agent or Firm:
Heiyoshi Odashima